ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation
Objective of the presented study is to introduce telemedicine system that integrates all of the most implemented features that appear in different mobile diabetes applications in addition to blood glucose: tracking of insulin or other medications, communication, diet management, physical activity, w...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Alliance for Innovation (EAI)
2015-12-01
|
| Series: | EAI Endorsed Transactions on Ambient Systems |
| Subjects: | |
| Online Access: | http://eudl.eu/doi/10.4108/eai.14-10-2015.2261966 |
| _version_ | 1819118378255646720 |
|---|---|
| author | Fedor Lehocki Peter Jackuliak Eva Žakovičová Tomáš Bacigal |
| author_facet | Fedor Lehocki Peter Jackuliak Eva Žakovičová Tomáš Bacigal |
| author_sort | Fedor Lehocki |
| collection | DOAJ |
| description | Objective of the presented study is to introduce telemedicine system that integrates all of the most implemented features that appear in different mobile diabetes applications in addition to blood glucose: tracking of insulin or other medications, communication, diet management, physical activity, weight, blood pressure, personal health record, education, social media, and alerts. Presented telemedicine system employs these features for management of Type 1 and Type 2 diabetes patients. Clinical evaluation after 3 months of intervention showed change of HbA1c in both patient groups was not only statistical significant but it had also a clinical dimension. The HbA1c decreased by 0,5% represents significant change for reduction of diabetic complications. Baseline for HbA1c in 29 T1DM patients: 8.1±1.5% versus 7.5±1.2% (P = 0.008). Baseline for HbA1c in 26 T2DM patients: 7.4±1.2% versus 6.8±1.1% (p=0.001). Results show statistically significant tendency to decrease in T2DM patients in weight 93.2±13.6kg compared to 91.9±14.2kg (P=0.08); and BMI 30.7±4.1 kg/m2 compared to 30.2±4.2 kg/m2 (P=0.08). |
| first_indexed | 2024-12-22T05:47:55Z |
| format | Article |
| id | doaj.art-9492285237e348b6939fae606e199ee2 |
| institution | Directory Open Access Journal |
| issn | 2032-927X |
| language | English |
| last_indexed | 2024-12-22T05:47:55Z |
| publishDate | 2015-12-01 |
| publisher | European Alliance for Innovation (EAI) |
| record_format | Article |
| series | EAI Endorsed Transactions on Ambient Systems |
| spelling | doaj.art-9492285237e348b6939fae606e199ee22022-12-21T18:36:57ZengEuropean Alliance for Innovation (EAI)EAI Endorsed Transactions on Ambient Systems2032-927X2015-12-013121510.4108/eai.14-10-2015.2261966ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness EvaluationFedor Lehocki0Peter Jackuliak1Eva Žakovičová2Tomáš Bacigal3Slovak University of Technology in Bratislava; fedor.lehocki@stuba.skComenius University, Faculty of MedicineDiacrin Diabetes and Endocrinology ClinicSlovak University of Technology in BratislavaObjective of the presented study is to introduce telemedicine system that integrates all of the most implemented features that appear in different mobile diabetes applications in addition to blood glucose: tracking of insulin or other medications, communication, diet management, physical activity, weight, blood pressure, personal health record, education, social media, and alerts. Presented telemedicine system employs these features for management of Type 1 and Type 2 diabetes patients. Clinical evaluation after 3 months of intervention showed change of HbA1c in both patient groups was not only statistical significant but it had also a clinical dimension. The HbA1c decreased by 0,5% represents significant change for reduction of diabetic complications. Baseline for HbA1c in 29 T1DM patients: 8.1±1.5% versus 7.5±1.2% (P = 0.008). Baseline for HbA1c in 26 T2DM patients: 7.4±1.2% versus 6.8±1.1% (p=0.001). Results show statistically significant tendency to decrease in T2DM patients in weight 93.2±13.6kg compared to 91.9±14.2kg (P=0.08); and BMI 30.7±4.1 kg/m2 compared to 30.2±4.2 kg/m2 (P=0.08).http://eudl.eu/doi/10.4108/eai.14-10-2015.2261966mhealthtelemedicinetelehealthdiabetesclinical study |
| spellingShingle | Fedor Lehocki Peter Jackuliak Eva Žakovičová Tomáš Bacigal ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation EAI Endorsed Transactions on Ambient Systems mhealth telemedicine telehealth diabetes clinical study |
| title | ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation |
| title_full | ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation |
| title_fullStr | ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation |
| title_full_unstemmed | ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation |
| title_short | ICT Based Diabetes Management System with Comprehensive Mobile Application: Clinical Usefulness Evaluation |
| title_sort | ict based diabetes management system with comprehensive mobile application clinical usefulness evaluation |
| topic | mhealth telemedicine telehealth diabetes clinical study |
| url | http://eudl.eu/doi/10.4108/eai.14-10-2015.2261966 |
| work_keys_str_mv | AT fedorlehocki ictbaseddiabetesmanagementsystemwithcomprehensivemobileapplicationclinicalusefulnessevaluation AT peterjackuliak ictbaseddiabetesmanagementsystemwithcomprehensivemobileapplicationclinicalusefulnessevaluation AT evazakovicova ictbaseddiabetesmanagementsystemwithcomprehensivemobileapplicationclinicalusefulnessevaluation AT tomasbacigal ictbaseddiabetesmanagementsystemwithcomprehensivemobileapplicationclinicalusefulnessevaluation |